Clinical trial
A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha…
NCT00001509 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001509 |
|---|---|
| Title | A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor |
| Official title | A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nephroblastoma, Neuroblastoma |
| Intervention type | Drug |
| Interventions | IFN-alpha with retinoic acid |
| Enrollment | 60 |
| Start date | Jul 1, 1996 |
| Completion | May 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: